Fresenius Kabi, LLC
Lake Zurich, IL Part of Centro Medico Imbanaco De Cali S A
- UEI
- C2TRNWNQKMD6
- CAGE
- 57KZ6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Centro Medico Imbanaco De Cali S A
Parent
J9TJRDC37Y89
- Fresenius Kabi, LLC C2TRNWNQKMD6
-
Centro Medico Imbanaco De Cali S A
Parent
J9TJRDC37Y89
- SAM.gov registration date
- Physical address
- 3 Corporate Dr, Lake Zurich, IL 60047, USA
- Website
- fresenius-kabi.com
- Founded
- 1912
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Atropine 0.4MGML x 20ML soln. For INJ., multi-dose vials 8MG and midazolam soln. For INJ., 5MG/ML, multi-dose vials | Office of the Assistant Secretary for Preparedness and Response | $7,878,120 | |
| 4572379145 ! Xylocaine 1% vial 20ML | Medical Supply Chain | $30 | |
| 4572378600 ! Diphenhydramine 50 MG/ML vialml | Medical Supply Chain | $70 | |
| 4572378592 ! Ketorolac 30 MG/ML vialml | Medical Supply Chain | $320 | |
| 4572322710 ! Diphenhydramine 50 MG/ML vialml | Medical Supply Chain | $70 |
About Fresenius Kabi, LLC
Fresenius Kabi, LLC, a foreign-owned subsidiary of Centro Medico Imbanaco De Cali S A, supplies injectable pharmaceutical products and biologics to the Department of Defense Medical Supply Chain, the Department of Veterans Affairs, and the Department of Health and Human Services as a prime contractor in full-and-open competition with no set-aside designations. The vendor operates from Lake Zurich, Illinois, and manufactures medicinal and botanical preparations under primary NAICS 325412 (Pharmaceutical Preparation Manufacturing).
Fresenius Kabi holds an overwhelming operational concentration in a single parent vehicle: the Defense Logistics Agency Troop Support Medical indefinite-delivery contract (SPE2D020D0009), which anchors 2,809 of the vendor's 2,819 total prime awards (100% of the prime footprint). The remaining ten awards span a Department of Veterans Affairs national acquisition center indefinite-delivery contract for Ustekinumab syringes and vials, the VA Veterans Health Administration, the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, and the NIH Clinical Center. On the DLA contract, Fresenius Kabi delivers a deep product portfolio of injectable medications — ketorolac, diphenhydramine, xylocaine (lidocaine), furosemide, rocuronium, protamine, atropine, dexamethasone, vancomycin, gentamicin, mannitol, methylprednisolone, and diprivan (propofol) — in vial and syringe formats. Recent representative delivery orders from the DLA vehicle carry low ceiling values (typically $23 to $1,000 per order), reflecting the granular medical-supply-line ordering pattern, with the highest recent order at $3,197.10 for ketorolac 30 mg/ml vials awarded February 24, 2026.
Customer concentration is extreme: the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 holds $709.8 million combined potential value across a single award, while the DLA Troop Support Medical program holds $50.9 million across 2,810 orders. The VA and HHS awards collectively represent $1.1 billion of the vendor's $1.15 billion total combined potential value, with the DLA awards accounting for the remaining $4.4% of the portfolio. Activity has averaged 500+ awards annually over the past four years, with 512 awards in 2025 and 321 awards year-to-date through June 2026. Only one award ($1.4 million combined potential value) faces ultimate completion inside the next twenty-four months, presenting minimal near-term recompete exposure across the portfolio. Of the combined potential value, $157.9 million (14%) has been obligated and invoiced to date across all awards. The vendor operates entirely as a prime; there is no subcontract footprint in the source data.
Contract vehicles
Quick answers
What is Fresenius Kabi, LLC's UEI?
Fresenius Kabi, LLC's Unique Entity ID (UEI) in SAM.gov is C2TRNWNQKMD6.
What is Fresenius Kabi, LLC's CAGE code?
Fresenius Kabi, LLC's CAGE code is 57KZ6.
What is Fresenius Kabi, LLC's primary NAICS code?
Fresenius Kabi, LLC's primary NAICS code is 424210 (Drugs and Druggists' Sundries Merchant Wholesalers).
Where is Fresenius Kabi, LLC located?
Fresenius Kabi, LLC's physical address in SAM.gov is 3 Corporate Dr, Lake Zurich, IL 60047, USA.
Is Fresenius Kabi, LLC registered in SAM.gov?
Yes. Fresenius Kabi, LLC's SAM.gov registration is active through May 20, 2027.
Who is Fresenius Kabi, LLC's parent company?
Fresenius Kabi, LLC is part of Centro Medico Imbanaco De Cali S A.
Which contract vehicles does Fresenius Kabi, LLC hold?
Fresenius Kabi, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Fresenius Kabi, LLC's most recent federal award?
Fresenius Kabi, LLC's most recent federal contract award is Atropine 0.4MGML x 20ML soln. For INJ., multi-dose vials 8MG and midazolam soln. For INJ., 5MG/ML, multi-dose vials (75A50326F80006), from Office of the Assistant Secretary for Preparedness and Response, on July 30, 2026.
On GovTribe
See Fresenius Kabi, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors